Symbols / TCMD Stock $25.07 +2.54% Tactile Systems Technology, Inc.

Healthcare • Medical Devices • United States • NGM
TCMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Ms. Sheri Louise Dodd
Exch · Country NGM · United States
Market Cap 570.35M
Enterprise Value 495.06M
Income 19.09M
Sales 329.52M
FCF (ttm) 34.58M
Book/sh 9.76
Cash/sh 3.72
Employees 1,086
Insider 10d
IPO Jul 28, 2016
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 30.57
Forward P/E 17.00
PEG 17.79
P/S 1.73
P/B 2.57
P/C
EV/EBITDA 13.78
EV/Sales 1.50
Quick Ratio 3.49
Current Ratio 4.03
Debt/Eq 7.29
LT Debt/Eq
EPS (ttm) 0.82
EPS next Y 1.48
EPS Growth 17.60%
Revenue Growth 21.00%
EPS Gr Q/Q 9.40%
Rev Gr Q/Q
Earnings (next) 2026-05-04
Earnings (prior) 2026-02-17
ROA 6.40%
ROE 8.77%
ROIC
Gross Margin 75.91%
Oper. Margin 18.12%
Profit Margin 5.79%
Shs Outstand 22.75M
Shs Float 22.08M
Insider Own 2.08%
Instit Own 98.67%
Short Float 7.40%
Short Ratio 6.46
Short Interest 1.66M
52W High 37.77
vs 52W High -33.62%
52W Low 8.61
vs 52W Low 191.17%
Beta 0.99
Impl. Vol. 0.20%
Rel Volume 1.10
Avg Volume 313.79K
Volume 346.09K
Target (mean) $38.00
Tgt Median $39.00
Tgt Low $32.00
Tgt High $42.00
# Analysts 4
Recom Buy
Prev Close $24.45
Price $25.07
Change 2.54%
About

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$25.07
Low
$32.00
High
$42.00
Mean
$38.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-18 main B. Riley Securities Neutral → Neutral $32
2026-02-18 main Piper Sandler Overweight → Overweight $42
2026-02-18 main BTIG Buy → Buy $38
2026-01-05 up Piper Sandler Neutral → Overweight $35
2025-11-04 main Lake Street Buy → Buy $32
2025-11-04 reit Piper Sandler Neutral → Neutral $20
2025-11-04 up BTIG Neutral → Buy $28
2025-10-03 init Lake Street — → Buy $24
2025-08-05 main B. Riley Securities Neutral → Neutral $13
2025-05-06 down Piper Sandler Overweight → Neutral $14
2025-02-19 down B. Riley Securities Buy → Neutral $18
2024-11-05 down BTIG Buy → Neutral
2024-09-26 init B. Riley Securities — → Buy $23
2023-08-08 main Oppenheimer Outperform → Outperform $30
2023-05-09 main Oppenheimer — → Outperform $24
2023-05-09 main Piper Sandler — → Overweight $30
2023-04-17 main BTIG — → Buy $28
2022-08-02 main Oppenheimer — → Outperform $18
2022-08-02 main Piper Sandler — → Overweight $25
2022-07-18 main BTIG — → Buy $27
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-09 PEARSON ANDREA Director 852 $0.00 $0
2026-02-24 DODD SHERI LOUISE Chief Executive Officer 10,993 $28.94 $318,144
2026-02-24 BURNS KRISTIE Officer 6,246 $28.94 $180,764
2026-02-24 BIRKEMEYER ELAINE M Chief Financial Officer 7,701 $28.94 $222,880
2026-02-23 DODD SHERI LOUISE Chief Executive Officer 15,240 $28.28 $431,245
2026-02-23 BURNS KRISTIE Officer 4,439 $28.28 $125,612
2026-02-23 BIRKEMEYER ELAINE M Chief Financial Officer 5,518 $28.28 $156,144
2026-02-20 DODD SHERI LOUISE Chief Executive Officer 47,967 $0.00 $0
2026-02-20 BURNS KRISTIE Officer 14,671 $0.00 $0
2026-02-20 BIRKEMEYER ELAINE M Chief Financial Officer 25,919 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
329.52
+12.47%
292.98
+6.76%
274.42
+11.20%
246.78
Operating Revenue
329.52
+12.47%
292.98
+6.76%
274.42
+11.20%
246.78
Cost Of Revenue
79.38
+4.04%
76.30
-3.78%
79.29
+11.98%
70.81
Reconciled Cost Of Revenue
75.18
+4.36%
72.03
-1.09%
72.83
-7.78%
78.97
Gross Profit
250.15
+15.44%
216.69
+11.05%
195.13
+10.89%
175.98
Operating Expense
220.87
+13.55%
194.51
+9.83%
177.09
-6.17%
188.73
Research And Development
8.48
-3.97%
8.83
+12.90%
7.82
+10.37%
7.09
Selling General And Administration
209.94
+14.63%
183.14
+8.25%
169.19
+1.18%
167.21
Selling And Marketing Expense
121.24
+8.24%
112.01
+4.57%
107.12
+0.66%
106.42
General And Administrative Expense
88.70
+24.70%
71.14
+14.60%
62.07
+2.10%
60.80
Other Gand A
88.70
+24.70%
71.14
+14.60%
62.07
+2.10%
60.80
Total Expenses
300.24
+10.87%
270.80
+5.62%
256.38
-1.22%
259.54
Operating Income
29.28
+32.00%
22.18
+22.95%
18.04
+241.41%
-12.76
Total Operating Income As Reported
29.28
+32.00%
22.18
+22.95%
18.04
+241.41%
-12.76
EBITDA
39.02
+20.56%
32.37
+22.34%
26.46
+1414.37%
1.75
Normalized EBITDA
39.02
+20.56%
32.37
+22.34%
26.46
+1414.37%
1.75
Reconciled Depreciation
6.64
-2.19%
6.79
+3.87%
6.54
+4.32%
6.27
EBIT
32.38
+26.60%
25.57
+28.40%
19.92
+257.01%
-12.69
Net Income
19.09
+12.54%
16.96
-40.52%
28.52
+259.60%
-17.87
Pretax Income
31.34
+33.42%
23.49
+48.95%
15.77
+201.92%
-15.47
Net Non Operating Interest Income Expense
2.06
+58.51%
1.30
+157.15%
-2.27
+16.68%
-2.73
Interest Expense Non Operating
1.04
-50.22%
2.08
-49.72%
4.15
+48.74%
2.79
Net Interest Income
2.06
+58.51%
1.30
+157.15%
-2.27
+16.68%
-2.73
Interest Expense
1.04
-50.22%
2.08
-49.72%
4.15
+48.74%
2.79
Interest Income Non Operating
3.10
-8.48%
3.38
+80.58%
1.87
+3023.33%
0.06
Interest Income
3.10
-8.48%
3.38
+80.58%
1.87
+3023.33%
0.06
Other Income Expense
0.00
-88.89%
0.01
+350.00%
0.00
-84.62%
0.01
Other Non Operating Income Expenses
0.00
-88.89%
0.01
+350.00%
0.00
-84.62%
0.01
Tax Provision
12.25
+87.67%
6.53
+151.23%
-12.74
-632.60%
2.39
Tax Rate For Calcs
0.00
+40.70%
0.00
+32.33%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
19.09
+12.54%
16.96
-40.52%
28.52
+259.60%
-17.87
Net Income From Continuing Operation Net Minority Interest
19.09
+12.54%
16.96
-40.52%
28.52
+259.60%
-17.87
Net Income From Continuing And Discontinued Operation
19.09
+12.54%
16.96
-40.52%
28.52
+259.60%
-17.87
Net Income Continuous Operations
19.09
+12.54%
16.96
-40.52%
28.52
+259.60%
-17.87
Normalized Income
19.09
+12.54%
16.96
-40.52%
28.52
+259.60%
-17.87
Net Income Common Stockholders
19.09
+12.54%
16.96
-40.52%
28.52
+259.60%
-17.87
Diluted EPS
0.82
+17.14%
0.70
-43.09%
1.23
+238.20%
-0.89
Basic EPS
0.83
+16.90%
0.71
-42.74%
1.24
+239.33%
-0.89
Basic Average Shares
22.87
-4.23%
23.88
+4.18%
22.93
+14.24%
20.07
Diluted Average Shares
23.30
-3.49%
24.14
+4.15%
23.18
+15.49%
20.07
Diluted NI Availto Com Stockholders
19.09
+12.54%
16.96
-40.52%
28.52
+259.60%
-17.87
Amortization
2.44
-3.44%
2.53
+3230.26%
0.08
-99.47%
14.43
Amortization Of Intangibles Income Statement
2.44
-3.44%
2.53
+3230.26%
0.08
-99.47%
14.43
Depreciation Amortization Depletion Income Statement
2.44
-3.44%
2.53
+3230.26%
0.08
-99.47%
14.43
Depreciation And Amortization In Income Statement
2.44
-3.44%
2.53
+3230.26%
0.08
-99.47%
14.43
Rent Expense Supplemental
10.69
-6.89%
11.48
-8.71%
12.58
+12.39%
11.19
Line Item Trend 2023-12-31
Total Assets
281.44
Current Assets
145.29
Cash Cash Equivalents And Short Term Investments
75.23
Cash And Cash Equivalents
61.03
Cash Financial
61.03
Other Short Term Investments
14.20
Receivables
43.17
Accounts Receivable
43.17
Inventory
22.53
Raw Materials
14.55
Finished Goods
7.98
Prepaid Assets
Other Current Assets
4.37
Total Non Current Assets
136.14
Net PPE
25.32
Gross PPE
33.91
Accumulated Depreciation
-8.58
Properties
0.00
Machinery Furniture Equipment
2.07
Construction In Progress
1.27
Other Properties
29.04
Leases
1.53
Goodwill And Other Intangible Assets
77.79
Goodwill
31.06
Other Intangible Assets
46.72
Non Current Accounts Receivable
10.94
Non Current Deferred Assets
19.38
Non Current Deferred Taxes Assets
19.38
Other Non Current Assets
2.72
Total Liabilities Net Minority Interest
87.80
Current Liabilities
41.06
Payables And Accrued Expenses
30.82
Payables
8.31
Accounts Payable
6.66
Current Accrued Expenses
22.51
Total Tax Payable
1.65
Income Tax Payable
1.47
Current Debt And Capital Lease Obligation
5.76
Current Debt
2.96
Other Current Borrowings
2.96
Current Capital Lease Obligation
2.81
Other Current Liabilities
4.47
Total Non Current Liabilities Net Minority Interest
46.74
Long Term Debt And Capital Lease Obligation
44.61
Long Term Debt
26.18
Long Term Capital Lease Obligation
18.44
Long Term Provisions
Tradeand Other Payables Non Current
0.45
Non Current Deferred Liabilities
Non Current Deferred Taxes Liabilities
Other Non Current Liabilities
Stockholders Equity
193.64
Common Stock Equity
193.64
Capital Stock
0.02
Common Stock
0.02
Preferred Stock
0.00
Share Issued
23.60
Ordinary Shares Number
23.60
Treasury Shares Number
0.00
Additional Paid In Capital
174.72
Retained Earnings
18.89
Total Equity Gross Minority Interest
193.64
Total Capitalization
219.82
Working Capital
104.24
Invested Capital
222.77
Total Debt
50.38
Net Debt
Capital Lease Obligations
21.24
Net Tangible Assets
115.86
Tangible Book Value
115.86
Current Notes Payable
Current Provisions
Non Current Accrued Expenses
1.68
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
42.81
+5.30%
40.66
+13.39%
35.85
+588.33%
5.21
Cash Flow From Continuing Operating Activities
42.81
+5.30%
40.66
+13.39%
35.85
+588.33%
5.21
Net Income From Continuing Operations
19.09
+12.54%
16.96
-40.52%
28.52
+259.60%
-17.87
Depreciation Amortization Depletion
6.64
-2.19%
6.79
+3.87%
6.54
+4.32%
6.27
Depreciation
3.00
+11.11%
2.70
+8.00%
2.50
Amortization Cash Flow
3.80
+0.00%
3.80
+0.00%
3.80
Depreciation And Amortization
6.64
-2.19%
6.79
+3.87%
6.54
+4.32%
6.27
Amortization Of Intangibles
3.80
+0.00%
3.80
+0.00%
3.80
Other Non Cash Items
-0.01
+99.68%
-2.48
-120.89%
11.85
Stock Based Compensation
8.36
+6.88%
7.82
+3.60%
7.55
-21.39%
9.60
Asset Impairment Charge
0.00
Deferred Tax
8.53
+699.25%
1.07
+105.51%
-19.38
-60456.25%
-0.03
Deferred Income Tax
8.53
+699.25%
1.07
+105.51%
-19.38
-60456.25%
-0.03
Operating Gains Losses
0.08
-74.68%
0.31
+10166.67%
0.00
-85.00%
0.02
Gain Loss On Sale Of PPE
0.08
-74.68%
0.31
+10166.67%
0.00
-85.00%
0.02
Change In Working Capital
0.12
-98.46%
7.71
-48.96%
15.10
+426.15%
-4.63
Change In Receivables
1.06
-88.43%
9.17
-61.43%
23.78
+252.80%
-15.56
Changes In Account Receivables
1.06
-88.43%
9.17
-61.43%
23.78
+252.80%
-15.56
Change In Inventory
4.64
+20.20%
3.86
+546.73%
0.60
+115.28%
-3.91
Change In Prepaid Assets
-6.90
-75.57%
-3.93
-5556.94%
0.07
+107.58%
-0.95
Change In Payables And Accrued Expense
2.67
+315.93%
-1.24
+89.10%
-11.35
-166.77%
17.00
Change In Accrued Expense
2.23
+78.23%
1.25
+118.51%
-6.78
-156.28%
12.04
Change In Payable
0.44
+117.50%
-2.49
+45.54%
-4.57
-192.20%
4.96
Change In Account Payable
-0.76
+30.27%
-1.09
+71.79%
-3.85
-177.67%
4.96
Change In Other Working Capital
-1.75
-244.07%
1.21
+188.10%
-1.38
Change In Other Current Assets
-1.36
-758.23%
-0.16
-107.88%
2.01
+1094.05%
0.17
Investing Cash Flow
-2.54
-1.52%
-2.50
-0.64%
-2.48
-29.96%
-1.91
Cash Flow From Continuing Investing Activities
-2.54
-1.52%
-2.50
-0.64%
-2.48
-29.96%
-1.91
Net PPE Purchase And Sale
-2.38
+0.00%
-2.38
-2.41%
-2.32
-31.37%
-1.77
Purchase Of PPE
-2.38
+0.50%
-2.39
-2.93%
-2.32
-30.56%
-1.78
Sale Of PPE
0.00
-100.00%
0.01
0.00
-100.00%
0.01
Capital Expenditure
-2.54
-1.04%
-2.51
-1.13%
-2.48
-29.22%
-1.92
Capital Expenditure Reported
-0.15
-32.48%
-0.12
+25.48%
-0.16
-12.14%
-0.14
Net Investment Purchase And Sale
0.00
Purchase Of Investment
Sale Of Investment
0.00
Net Business Purchase And Sale
0.00
0.00
Purchase Of Business
0.00
0.00
Net Intangibles Purchase And Sale
-0.14
Purchase Of Intangibles
-0.14
Financing Cash Flow
-51.20
-961.30%
-4.82
-184.19%
5.73
+159.69%
-9.60
Cash Flow From Continuing Financing Activities
-51.20
-961.30%
-4.82
-184.19%
5.73
+159.69%
-9.60
Net Issuance Payments Of Debt
-26.25
-775.00%
-3.00
+84.81%
-19.75
-229.17%
-6.00
Issuance Of Debt
0.00
0.00
-100.00%
8.25
0.00
Repayment Of Debt
-26.25
-775.00%
-3.00
+89.29%
-28.00
-366.67%
-6.00
Long Term Debt Issuance
0.00
0.00
-100.00%
8.25
0.00
Long Term Debt Payments
-26.25
-775.00%
-3.00
+89.29%
-28.00
-366.67%
-6.00
Net Long Term Debt Issuance
-26.25
-775.00%
-3.00
+84.81%
-19.75
-229.17%
-6.00
Short Term Debt Issuance
Net Short Term Debt Issuance
Net Common Stock Issuance
-26.56
-657.16%
-3.51
-110.13%
34.62
0.00
Common Stock Payments
-26.56
-657.16%
-3.51
0.00
0.00
Repurchase Of Capital Stock
-26.56
-657.16%
-3.51
0.00
0.00
Proceeds From Stock Option Exercised
1.61
-4.16%
1.68
+8.30%
1.55
+8.06%
1.44
Net Other Financing Charges
-10.70
-112.34%
-5.04
Changes In Cash
-10.92
-132.76%
33.33
-14.76%
39.10
+720.70%
-6.30
Beginning Cash Position
94.37
+54.62%
61.03
+178.32%
21.93
-22.32%
28.23
End Cash Position
83.45
-11.57%
94.37
+54.62%
61.03
+178.32%
21.93
Free Cash Flow
40.28
+5.58%
38.15
+14.30%
33.37
+914.72%
3.29
Interest Paid Supplemental Data
1.22
-42.17%
2.11
-53.82%
4.56
+108.60%
2.19
Income Tax Paid Supplemental Data
2.50
-63.59%
6.87
-6.62%
7.35
+16611.36%
0.04
Amortization Of Securities
0.00
Change In Income Tax Payable
1.19
+185.04%
-1.40
-94.73%
-0.72
Change In Tax Payable
1.19
+185.04%
-1.40
-94.73%
-0.72
Common Stock Issuance
0.00
0.00
-100.00%
34.62
0.00
Issuance Of Capital Stock
0.00
0.00
-100.00%
34.62
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category